Bajaj, Madhu S <br/><br/>
Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant.  [electronic resource] 

 -  The Journal of biological chemistry  Feb 2011 
 - 4329-40 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1083-351X 
<br/><br/><label>Standard No.: </label>10.1074/jbc.M110.191163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Substitution<br/>Animals<br/>Antifibrinolytic Agents--chemistry<br/>Aprotinin--chemistry<br/>Blood Coagulation Factors--chemistry<br/>Disease Models, Animal<br/>Escherichia coli<br/>Fibrinolysis--drug effects<br/>Glycoproteins--chemistry<br/>Hemorrhage--drug therapy<br/>Humans<br/>Mice<br/>Mutation, Missense<br/>Protein Folding<br/>Protein Structure, Tertiary<br/>Recombinant Proteins--chemistry<br/>Structure-Activity Relationship<br/>Tranexamic Acid--chemistry